Silvia Ferrero

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes

Stefania Ronzoni, Teresa Cobo, Rohan D’Souza et al. · American Journal of Obstetrics and Gynecology · 2022 · 47 citations

Medicine, Obstetrics, Pediatrics +17

Development and validation of a multivariable prediction model of spontaneous preterm delivery and microbial invasion of the amniotic cavity in women with preterm labor

Teresa Cobo, Victoria Aldecoa‐Bilbao, F. Figueras et al. · American Journal of Obstetrics and Gynecology · 2020 · 46 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up.

Francesco Mauri, Patrick Maisonneuve, Orazio Caffo et al. · International Journal of Oncology · 1999 · 24 citations

Medicine, Cancer Biology, Oncology +15

Mid-Trimester Cervical Consistency Index and Cervical Length to Predict Spontaneous Preterm Birth in a High-Risk Population

Núria Baños, Carla Julià, N. Lorente et al. · American Journal of Perinatology Reports · 2018 · 20 citations · Full text

Medicine, Maternal Health, Obstetrics +17